RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,617,409 | +1.2% | 97,317 | +13.8% | 0.00% | 0.0% |
| Q2 2023 | $1,598,738 | +26612.4% | 85,494 | -73.8% | 0.00% | -50.0% |
| Q1 2023 | $5,985 | -8.6% | 326,174 | -1.4% | 0.00% | -33.3% |
| Q4 2022 | $6,548 | -99.9% | 330,728 | +12.5% | 0.00% | 0.0% |
| Q3 2022 | $7,076,000 | +254.5% | 294,088 | +168.9% | 0.00% | +200.0% |
| Q2 2022 | $1,996,000 | -34.1% | 109,376 | -24.7% | 0.00% | 0.0% |
| Q1 2022 | $3,030,000 | +12.3% | 145,336 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,699,000 | -9.7% | 145,336 | -9.7% | 0.00% | 0.0% |
| Q3 2021 | $2,988,000 | +198.2% | 160,934 | +198.3% | 0.00% | – |
| Q2 2021 | $1,002,000 | +7.3% | 53,957 | +28.2% | 0.00% | – |
| Q1 2021 | $934,000 | +7.7% | 42,091 | -4.1% | 0.00% | – |
| Q4 2020 | $867,000 | -37.9% | 43,882 | +1.1% | 0.00% | -100.0% |
| Q3 2020 | $1,397,000 | +0.3% | 43,399 | -9.6% | 0.00% | 0.0% |
| Q2 2020 | $1,393,000 | – | 47,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |